UPDATED Mar 26, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ABI | €55.82 | 1.2% | -4.5% | €110.0b | €66.34 | PE22.3x | E14.0% | 1.5% | Food, Beverage & Tobacco | ||
KBC | €69.02 | 0.4% | 12.1% | €27.9b | €73.24 | PB1.2x | E-2.4% | 6.0% | Banks | ||
UCB | €114.50 | 5.7% | 42.5% | €21.7b | €117.81 | PE63.3x | E26.4% | 1.2% | Pharmaceuticals & Biotech |